Press release
Orthobiologics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Increasing prevalence of injury and facture due to falls and road accidents are expected to augment growth of the orthobiologics market
According to World Health Organization (WHO), 2017, fatal falls are the second-leading cause of accidental injury and factures worldwide. Every year around 646000 individuals die from falls, globally. Increasing incidence of fall is expected to increase the chances of fractures, which in turn, is expected to create a highly conductive environment for growth of the orthobiologics market over the forecast period.
According to World Health Organization (WHO), in 2017, around 1.25 million deaths were recorded and 20 to 50 million people suffered from severe injuries and fractures. Increasing prevalence of factures due to road accidents is expected to boost growth of the orthobiologics market in the near future. According to National Institute of Health (NIH), in 2016, around 8.5%, accounting for around 617 million of the world population was aged 65 years and above. Growing geriatric population, which is highly susceptible to injuries and fractures due to fragile skeletal framework, is increasing the prevalence of orthopedic disorders, in turn, driving growth of the orthobiologics market. The major factor restraining market growth is the high cost associated with orthobiologics-based treatments.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1306
Global Orthobiologics Market Taxonomy
The global orthobiologics market is segmented on the basis of product type, application, and end user.
By Product Type
-Demineralized Bone Matrix (DBM)
-Allograft
-Bone Morphogenetic Protein (BMP)
-Viscosupplementation Products
-Synthetic Bone Substitutes
-Stem Cell Therapy
By Application
-Osteoarthritis and Degenerative Arthritis
-Spinal Fusion
-Fracture Recovery
-Soft Tissue Injuries
Maxillofacial and Dental Applications
By End User
-Hospitals
-Ambulatory Care Centers
-Dental Clinics
North America is expected to hold a dominant position due to rapid development of new innovative products by key players present in region
North America is expected to hold a dominant position in the orthobiologics market due to rampant research activities and rapid development of innovative products by key players present in the region. For instance, in 2015, NuVasive Inc.—U.S.-based company—launched its new innovative biologics technology, AttraX Putty, which is a synthetic bone graft, indicated in posterolateral spinal surgery as an autograft extender. Asia Pacific is expected to witness rapid growth, owing to growing geriatric population in the region. According to The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), 2016, the Asia Pacific region recorded around 60 percent of the geriatric population across the globe. The region recorded around 547 million people aged 65 years and above, which is projected to reach up to 1.3 billion by 2050.
Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/orthobiologics-market-1306
Major players in the market are focusing on inorganic growth strategies such as mergers and acquisitions, to enhance their foothold in the global orthobiologics market. For instance, in May 2015, Bone Biologics Corp. collaborated with the University of California for the development of Nell-1, a bone growth stimulator orthobiological product.
Key players operating in the orthobiologics market include Medtronic Plc, DePuy Synthes, Inc., Zimmer Biomet Holdings, Inc., Bone Biologics Corp, Harvest Technologies Corporation, Globus Medical, Inc., Smith & Nephew plc. NuVasive Inc., Stryker Corporation, and Genzyme.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orthobiologics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here
News-ID: 947074 • Views: …
More Releases from Biotechnology by CMI
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management
Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerve deterioration or permanent damage. The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS) and secondary progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing neurological symptoms, PPMS is the rare form characterized by gradual progression…
Ebola Vaccine Market - Global Industry Insights, 2017-2025
Increasing number of Ebola cases in affected regions and new vaccine development for this are expected to be factors driving growth of the market
Increasing mortality rates due to Ebola is expected to be a major factor for growth of the market. According to World Health Organization, in January 2018, around 50% people infected with EVD, have died. African countries such as Siberia, Sierra Leone, Guinea, Democratic Republic of Congo, Senegal,…
Oncology Biosimilars Market-Opportunity Analysis, 2017-2025
Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries…
Kidney Transplant Holds The Maximum Share Of Organ Transplant Market Due To Risi …
Organ transplantation is the surgical operation in which a healthy organ is removed from one person and transplanted to another person whose organ is failed or damaged. In the organ transplantation, the donated organ may be from living donor, deceased donor, or from an animal. Whereas in some cases an artificial organ is used in the transplantation procedure. Organ transplantation gives new life to the individual with damaged or failed…
More Releases for Orthobiologics
Orthobiologics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On –“ Orthobiologics Market Objectives and Detailed Study 2018”.
Description:-
The Orthobiologics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Orthobiologics market size to maintain the average annual growth rate of 3.04% from 4260 million $ in 2014 to 4660 million $ in 2017, The analysts believe that in the next few years, Orthobiologics…
Global Orthobiologics Market Analysis & Overview 2022
Qyresearchreports include new market research report "Global Orthobiologics Market Size, Status and Forecast 2022" to its huge collection of research reports.
The report on the global market for Orthobiologics tries to help stakeholders in acquiring a 360-degree knowledge of the prevalent trends and pitfalls in the market. It is a repository of crucial information that can help companies in their important decision making procedures. The report examines the various growth drivers…
Global Orthobiologics Market $6.2 Billion by 2021
Orthobiologics Market Analysis and Forecast 2017-2021 report estimates the global orthobiologics market to reach nearly $6.2 Billion in 2021, at a CAGR of 6.2% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global orthobiologics market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global orthobiologics market segmentation is based on product types (allograft, bone morphogenetic proteins, demineralized bone matrix,…
Orthobiologics Market Intelligence Report for Comprehensive Information
Biologic treatment has made a significant impact in orthopedic surgery, incorporating patient’s own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand for…
Global Orthobiologics Sales Market Report 2017
In this report, the global Orthobiologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report studies Orthobiologics in Global Sales market , especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market…
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc.
Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/
The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The global orthobiologics market segmentation is based on product types (allograft, bone…
